A new therapy shows promise for patients with mild idiopathic pulmonary fibrosis. According to researchers, inhaled N-acetylcysteine (NAC) monotherapy preserves more lung function in some idiopathic pulmonary fibrosis (IPF) patients than no therapy.
Results 1 to 1 of 1
- May 18th, 2010 #1Bot
- Member since
- Jul 2007
- Posts
- 20,743
Hope for patients with mild idiopathic pulmonary fibrosis
QuoteRelated Posts
-
Blood proteins predict survival in idiopathic pulmonary fibrosis, team finds
By MedBot in forum Medical NewsReplies: 0Last Post: October 25th, 2011, 10:01 PM -
Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful
By MedBot in forum Medical NewsReplies: 0Last Post: October 21st, 2011, 09:06 PM -
Heartburn treatment may extend survival in idiopathic pulmonary fibrosis (IPF) patients
By MedBot in forum Medical NewsReplies: 0Last Post: July 19th, 2011, 10:07 PM -
Idiopathic pulmonary fibrosis drug fails in new trial
By MedBot in forum Medical NewsReplies: 0Last Post: April 8th, 2011, 07:07 PM -
American Thoracic Society issues statement on the treatment of idiopathic pulmonary fibrosis
By MedBot in forum Medical NewsReplies: 0Last Post: March 18th, 2011, 02:03 AM
Posting Permissions
The information provided on this site is meant to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
All times are GMT. The time now is 02:35 AM.